Lauren Moore

Welcome to Research Integrity Research Foundation

Bachelor of Science in Chemistry – Minor in Biology
Kentucky Wesleyan College, Owensboro, Kentucky (2011)

Clinical Research Coordinator/Regulatory Specialist
Research Integrity, LLC – Owensboro, Kentucky (2025 – Present)
Conduct clinical research studies to document the efficacy and safety of adult and pediatric health care products, including devices. Maintain contact with a large number of sponsors and CROs as required for coordinating.
Scientist – Analytical Development
KBio – Owensboro, Kentucky (2021 – 2025)
Chemist
Brenntag Mid South – Henderson, Kentucky (2018 – 2021)
Laboratory Technician
Aleris Rolled Products – Lewisport, Kentucky (2016 – 2018)
Research Technologist
Owensboro Cancer Research Program – Owensboro, Kentucky (2011 – 2016)

IATA: computer training; current certificate holder
GCP CITI: current certificate holder
EKG Acquisitions: site training per cardiologist; lead placement per sponsor recommendations
EKG Transmission: per sponsor & vendor training; both computer/phone line
Centrifuge training: by site including cup size, RPMs, and calibrations
Lab Sample Processing: sponsor, central lab specific, local lab & site training

Production of recombinant cholera toxin B subunit in Nicotiana benthamiana using GENEWARE® tobacco mosaic virus vector. Lauren Moore, Krystal Hamorsky, and Nobuyuki Matoba. Methods in Molecular Biology, 2016.
N-Glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential. Krystal Hamorsky, J. Calvin Kouokam, Jessica McMullen, Bailey Nelson, Lauren J. Moore, Adam Husk, Hiroyuki Kajiura, Kazuhito Fujiyama, Nobuyuki Matoba. Scientific Reports, 2015.
Rapid and Scalable Plant-based Production of a Cholera Toxin B Subunit Variant to Aid in Mass Vaccination against Cholera Outbreaks. Krystal Teasley Hamorsky, J. Calvin Kouokam, Lauren Bennett, Keegan Baldauf, Hiroyuki Kajiura, Kazuhito Fujiyama, Nobuyuki Matoba. PLoS Neglected Tropical Diseases, e2046, 2013.
Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana plants and its utility in combination microbicides. Krystal Teasley Hamorsky, Tiffany Grooms-Williams, Adam Husk, Lauren Bennett, Kenneth Palmer, Nobuyuki Matoba. Antimicrobial Agents and Chemotherapy, 2013.

A Phase 3, randomized, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD (BI 456906)

Welcome to Research Integrity Research Foundation